Abstract
Osteoprotegerin (OPG), the soluble decoy receptor of RANKL is released by bone marrow osteoblasts and plays an important role in physiological osteoblastogenesis and pathological bone disease. In earlier studies, we have shown that generated stromal cell lines from the aorta-gonad-mesonephros (AGM)-region serving as good supporters of murine and human hematopoietic progenitor cell (HPC) expansion highly express OPG detected by microarray analysis. Here, we investigated the role of OPG to HPC expansion in vitro. Addition of OPG leads to an enhanced expansion of HPC in liquid culture. In addition, progenitor cell function, measured by colony and cobblestone formation, was increased. The observed effects were partially antagonized by addition of RANKL.
In conclusion, these findings suggest an important role of OPG maintaining progenitor cell function in the osteoblastic niche.
Keywords: Hematopoietic progenitor cells, osteoprotegerin, RANKL, osteoblastogenesis, aorta-gonad-mesonephros, Stromal cell Culture, primitive embryonic fibroblasts, niche, (AGM)-Region
Current Stem Cell Research & Therapy
Title: Osteoprotegerin Positively Regulates Hematopoietic Progenitor Cells
Volume: 7 Issue: 1
Author(s): Eric Schweikle, Tina Baessler, Sedat Yildirim, Lothar Kanz, Robert Mohle and Katja C. Weisel
Affiliation:
Keywords: Hematopoietic progenitor cells, osteoprotegerin, RANKL, osteoblastogenesis, aorta-gonad-mesonephros, Stromal cell Culture, primitive embryonic fibroblasts, niche, (AGM)-Region
Abstract: Osteoprotegerin (OPG), the soluble decoy receptor of RANKL is released by bone marrow osteoblasts and plays an important role in physiological osteoblastogenesis and pathological bone disease. In earlier studies, we have shown that generated stromal cell lines from the aorta-gonad-mesonephros (AGM)-region serving as good supporters of murine and human hematopoietic progenitor cell (HPC) expansion highly express OPG detected by microarray analysis. Here, we investigated the role of OPG to HPC expansion in vitro. Addition of OPG leads to an enhanced expansion of HPC in liquid culture. In addition, progenitor cell function, measured by colony and cobblestone formation, was increased. The observed effects were partially antagonized by addition of RANKL.
In conclusion, these findings suggest an important role of OPG maintaining progenitor cell function in the osteoblastic niche.
Export Options
About this article
Cite this article as:
Schweikle Eric, Baessler Tina, Yildirim Sedat, Kanz Lothar, Mohle Robert and C. Weisel Katja, Osteoprotegerin Positively Regulates Hematopoietic Progenitor Cells, Current Stem Cell Research & Therapy 2012; 7 (1) . https://dx.doi.org/10.2174/157488812798483458
DOI https://dx.doi.org/10.2174/157488812798483458 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Comparative Effectiveness of Pioglitazone and Rosiglitazone in Type 2 Diabetes, Prediabetes,and the Metabolic Syndrome: A Meta-Analysis
Current Diabetes Reviews Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease
Current Respiratory Medicine Reviews Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews Central Hemodynamics in Risk Assessment Strategies: Additive Value Over and Above Brachial Blood Pressure
Current Pharmaceutical Design Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease
Current Vascular Pharmacology Oxidative Stress and Endothelial Dysfunction: Say NO to Cigarette Smoking!
Current Pharmaceutical Design Carotid Ultrasound in One, Two and Three Dimensions
Vascular Disease Prevention (Discontinued) Role of Nitric Oxide in Physiology and Pathology of the Gastrointestinal Tract
Mini-Reviews in Medicinal Chemistry Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Radiation-Induced Extracranial Carotid Stenosis
Vascular Disease Prevention (Discontinued) Atherosclerosis - New Targets and Therapeutics
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Mesenchymal Stem Cells and C-type Natriuretic Peptide Signaling: A Proposal for a New Treatment Approach for Skeletal Dysplasias
Current Stem Cell Research & Therapy Chinese Medicinal Herbs as Source of Antioxidant Compounds – Where Tradition Meets the Future
Current Medicinal Chemistry Pathophysiology of Erectile Dysfunction
Current Drug Targets Second-Generation Antipsychotic Agents: A Review of Safety Profiles
Current Psychiatry Reviews Prevalence of Venous Thromboembolism in Hip and Knee Arthroplasty Patients Admitted for Comprehensive Inpatient Rehabilitation
Vascular Disease Prevention (Discontinued) Hepatobiliary Diseases and Insulin Resistance
Current Medicinal Chemistry Migraine and Coronary Artery Disease: An Open Study on the Genetic Polymorphism of the 5, 10 Methylenetetrahydrofolate (MTHFR) and Angiotensin I-Converting Enzyme (ACE) Genes
Central Nervous System Agents in Medicinal Chemistry Transient Receptor Potential (TRP) Cation Channels in Diabetes
Current Topics in Medicinal Chemistry